Sabiad closed a funding round (amount undisclosed) in Jan 2024. The company is based in Heerenveen, Netherlands. Investors in the round: Pharma Connect Capital (PCC). Data as of 23 Sept 2026.
Amount undisclosed or unconverted.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
